Literature DB >> 1717048

Dark-induced supersensitivity of dopamine D-1 and D-2 receptors in rat retina.

J Z Nowak1, B Sek, M Schorderet.   

Abstract

Light deprivation of rat retina leads to a rapid (within 6 h) development of a state of supersensitivity (upregulation) of dopamine D-1 receptors (positively coupled to adenylate cyclase), which are essentially involved in the modulation by light of the electrical activity and communication between horizontal cells. In contrast, the supersensitivity of D-2 receptors (negatively coupled to cAMP generating system) appears to develop only after 2 days (better after 4 days) of dark adaptation, although these receptors are linked to multiple light-dependent retinal functions. These results suggest the existence of different mechanisms of sensory adaptation for these two subtypes of dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717048     DOI: 10.1097/00001756-199108000-00004

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

1.  Asthma: is there an airway receptor barrier?

Authors:  B A Hills
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 2.  Dopamine receptor localization in the mammalian retina.

Authors:  J Nguyen-Legros; C Versaux-Botteri; P Vernier
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

Review 3.  Dopamine and retinal function.

Authors:  Paul Witkovsky
Journal:  Doc Ophthalmol       Date:  2004-01       Impact factor: 2.379

Review 4.  Role of dopamine in distal retina.

Authors:  E Popova
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2014-04-12       Impact factor: 1.836

5.  Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).

Authors:  Barbara Nowacka; Wojciech Lubiński; Krystyna Honczarenko; Andrzej Potemkowski; Krzysztof Safranow
Journal:  Doc Ophthalmol       Date:  2015-05-14       Impact factor: 2.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.